Colorectal Cancer Treatment Market Scope And Analysis

Report Code : TIPRE00038988
Category : Life Sciences

No. of Pages : 150

Buy Now

Colorectal Cancer Treatment Market Analysis, Scope, and Growth by 2030

Buy Now

Colorectal Cancer Treatment Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 18.810 Billion
Market Size by 2030	US$ 23.978 Billion
Global CAGR (2022 - 2030)	3.1%
Historical Data	2020-2022
Forecast period	2022-2030
Segments Covered	By Treatment Type Surgery Chemotherapy Immunotherapy Targeted Therapy By Age Group Below 49 Years 50 64 Years Above 65 Years By End User Hospitals Specialty Clinics Home Care
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Genentech Inc Eli Lilly and Company Pfizer Inc Takeda Pharmaceuticals Bristol Myers Squibb Merck Bayer AG Regeneron Pharmaceuticals Inc Novartis AG

Competitive Landscape and Key Companies:

Genentech Inc, Eli Lilly and Company, Pfizer Inc, Takeda Pharmaceuticals, Bristol Myers Squibb, Merck, Bayer AG, Regeneron Pharmaceuticals Inc, Novartis AG, and Ipsen Biopharmaceuticals Inc are among the prominent players profiled in the colorectal cancer treatment market report. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem. These companies focus on geographic expansions and new product launches to meet the growing demand from consumers worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large customer base, subsequently facilitating market expansion.